INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
51 hedge funds and large institutions have $118M invested in Inozyme Pharma in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less capital invested
Capital invested by funds: $203M → $118M (-$84.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
51
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.59M | |
| 2 | +$895K | |
| 3 | +$857K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$528K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$463K |
Top Sellers
| 1 | -$4.23M | |
| 2 | -$1.34M | |
| 3 | -$835K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$762K |
| 5 |
BlackRock
New York
|
-$435K |